BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26542585)

  • 1. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
    Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
    Nakhlis F; Baker GM; Pilewskie M; Gelman R; Calvillo KZ; Ludwig K; McAuliffe PF; Willey S; Rosenberger LH; Parker C; Gallagher K; Jacobs L; Feldman S; Lange P; DeSantis SD; Schnitt SJ; King TA
    Ann Surg Oncol; 2021 May; 28(5):2573-2578. PubMed ID: 33047246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
    Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
    Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision.
    Lavoué V; Graesslin O; Classe JM; Fondrinier E; Angibeau H; Levêque J
    Breast; 2007 Oct; 16(5):533-9. PubMed ID: 17629481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
    Crisi GM; Mandavilli S; Cronin E; Ricci A
    Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
    Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
    Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
    Murray MP; Luedtke C; Liberman L; Nehhozina T; Akram M; Brogi E
    Cancer; 2013 Mar; 119(5):1073-9. PubMed ID: 23132235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
    Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
    Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
    AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
    Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
    Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
    Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
    Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
    Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
    Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular neoplasia: frequency and association with other breast lesions.
    Gomes DS; Balabram D; Porto SS; Gobbi H
    Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
    Bodian CA; Perzin KH; Lattes R
    Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up.
    Muller KE; Roberts E; Zhao L; Jorns JM
    Arch Pathol Lab Med; 2018 Mar; 142(3):391-395. PubMed ID: 29160721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?
    Niell B; Specht M; Gerade B; Rafferty E
    AJR Am J Roentgenol; 2012 Oct; 199(4):929-35. PubMed ID: 22997389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens.
    Uzan C; Mazouni C; Ferchiou M; Ciolovan L; Balleyguier C; Mathieu MC; Vielh P; Delaloge S
    Ann Surg Oncol; 2013 Sep; 20(9):2850-7. PubMed ID: 23702641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.